Unleashing Innovation 2021: A Sustainable Future for Life Sciences in London
London Life Sciences Real Estate Demand Report October 2021
Q&A: Our Joint Investment Call with Spex Capital. Applications open on 15th September 2021 for digital health and medtech companies seeking investment. Here is an overview of what is on offer, who is involved and who is eligible. Detailed F&Q and application link coming soon.
London: An Innovation Hub for Health & Life Sciences Through the Application of Data & AI
16 Jun 2021
Our new report on London as a leader in Data & AI in life sciences
The health and life sciences ecosystem across the UK has reacted rapidly to the challenge of tackling the COVID-19 outbreak – through research, innovation and collaboration. The efforts in London and the Greater South East alone have been a real testimony to the innovation and expertise within life sciences that is driving global excellence.
The Covid-19 disease outbreak, the subsequent restrictions and the lockdown measures adopted by governments worldwide including the UK, have significantly affected the work of SMEs and start-up companies.
This framework was developed over a six-month period through an agile, user-centric process by a working group led by NHS England including MedCity, NICE, Public Health England and Digital Health London.
In recent years the supply of property serving the Life Sciences sector in London has been believed to have been inadequate. MedCity commissioned this study to scrutinise the issue and deliver an objective analysis that provides a platform from which more informed infrastructure investment decisions can be made into the future – by both public and private sector organisations.
Fundamental to the research success of the region are the National Institute of Health Research (NIHR) Biomedical Research Centres (BRCs). The BRC objective was established in England in 2007 as a way of partnering academic institutions and NHS trusts, with the goal of translating advances in biomedical research into benefits for patients.